Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
52.46 USD | -0.51% | -10.90% | +181.89% |
Jun. 04 | Health Care Climbs on Defensive Bias - Health Care Roundup | DJ |
Jun. 04 | Sector Update: Health Care Stocks Steady Pre-Bell Tuesday | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 5.78B |
---|---|---|---|---|---|
Net income 2024 * | -119M | Net income 2025 * | -171M | EV / Sales 2024 * | - |
Net cash position 2024 * | 895M | Net cash position 2025 * | 749M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-46.9
x | P/E ratio 2025 * |
-33.9
x | Employees | 28 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.1% |
Latest transcript on Viking Therapeutics, Inc.
1 day | -0.51% | ||
1 week | -10.90% | ||
Current month | -15.74% | ||
1 month | -28.76% | ||
3 months | -21.82% | ||
6 months | +186.04% | ||
Current year | +181.89% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Lian
FOU | Founder | 58 | 12-09-23 |
Gregory Zante
DFI | Director of Finance/CFO | 53 | 16-01-04 |
Marianne Mancini
COO | Chief Operating Officer | 59 | 15-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Matthew Foehr
BRD | Director/Board Member | 51 | 14-04-30 |
J. Singleton
BRD | Director/Board Member | 71 | 14-04-30 |
Charles Rowland
BRD | Director/Board Member | 65 | 17-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.13% | 2 M€ | -.--% | ||
0.06% | 7 M€ | -.--% | - | |
0.00% | 32 M€ | +4.82% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-12 | 52.46 | -0.51% | 2,911,109 |
24-06-11 | 52.73 | -6.47% | 3,318,564 |
24-06-10 | 56.38 | +0.70% | 1,857,261 |
24-06-07 | 55.99 | +1.78% | 2,558,274 |
24-06-06 | 55.01 | -6.57% | 3,897,689 |
Delayed Quote Nasdaq, June 12, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+181.89% | 5.78B | |
+16.93% | 123B | |
+17.01% | 111B | |
-7.23% | 23.63B | |
+3.35% | 22.58B | |
-14.45% | 17.26B | |
-6.79% | 17.6B | |
-37.63% | 17.61B | |
+2.17% | 13.55B | |
+24.42% | 11.34B |
- Stock Market
- Equities
- VKTX Stock